신장결석 치료 시장 : 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of kidney stone management Market

The global kidney stone management market was valued at USD 1.98 billion in 2025 and is projected to grow from USD 2.09 billion in 2026 to USD 3.37 billion by 2034, registering a CAGR of 6.10% during the forecast period. North America dominated the global market with a 36.03% market share in 2025, supported by the high prevalence of kidney stone disease, increasing adoption of minimally invasive treatment procedures, and the presence of advanced healthcare infrastructure.

Kidney stone management includes a range of diagnostic and treatment procedures designed to remove or break down stones formed in the kidneys or urinary tract. The growing burden of nephrolithiasis worldwide, combined with technological innovations in ureteroscopes, laser lithotripsy systems, and minimally invasive surgical devices, is significantly driving market expansion. Rising healthcare spending, increasing patient awareness, and improved access to advanced treatment options are further contributing to steady market growth.

Rising Adoption of Advanced Stone Removal Technologies Emerging as a Key Market Trend

Continuous innovation in kidney stone treatment technologies is transforming patient care and improving surgical outcomes. Healthcare providers are increasingly adopting advanced solutions such as miniaturized surgical instruments, disposable flexible ureteroscopes, fiber-optic imaging systems, and holmium laser lithotripsy technologies. These innovations reduce procedure time, minimize bleeding, improve stone clearance rates, and shorten hospital stays.

One notable advancement is the adoption of MOSES laser technology, which enables efficient fragmentation of kidney stones while minimizing damage to surrounding tissues. Such technological progress is encouraging hospitals and specialty clinics to upgrade their urology departments, creating favorable growth opportunities for manufacturers worldwide.

Market Drivers

Increasing Prevalence of Kidney Stone Disease Driving Market Growth

The growing incidence of kidney stone disease remains the primary factor fueling market demand. According to various clinical studies, nearly 12% of the global population may experience kidney stones during their lifetime, while recurrence rates remain significantly high. Lifestyle disorders such as obesity, diabetes, hypertension, poor dietary habits, and inadequate hydration continue to increase the risk of stone formation.

As the number of patients requiring treatment continues to rise, hospitals and healthcare providers are investing in advanced kidney stone management systems that offer higher success rates with fewer complications.

Growing Preference for Minimally Invasive Procedures

Minimally invasive procedures have become the preferred treatment option for kidney stone removal due to reduced pain, faster recovery, shorter hospitalization, and lower recurrence rates. Techniques including ureteroscopy, extracorporeal shock wave lithotripsy (ESWL), and percutaneous nephrolithotomy (PCNL) are increasingly replacing conventional open surgeries.

Improved clinical outcomes and continuous technological enhancements in endoscopic devices are further strengthening the adoption of minimally invasive kidney stone treatment worldwide.

Market Restraint

Despite positive growth prospects, certain treatment-related complications continue to restrict market expansion. Shock wave lithotripsy may lead to bleeding, urinary obstruction caused by fragmented stones, infections, reduced kidney function, and elevated blood pressure in some patients. These potential side effects encourage physicians to carefully evaluate treatment suitability, limiting the widespread adoption of certain procedures.

Market Segmentation

By Type

The ureteroscopy segment is expected to maintain the largest market share throughout the forecast period. Its leadership is attributed to high procedural success rates, lower recurrence risk, minimal invasiveness, and continuous advancements in flexible ureteroscope technology. Meanwhile, lithotripsy and PCNL procedures continue to witness steady adoption for treating larger or complex kidney stones.

By End User

Hospitals accounted for the largest market share and are expected to retain their dominance through 2034. The availability of advanced surgical infrastructure, experienced urologists, and favorable reimbursement policies supports hospital-based procedures. Specialty clinics are anticipated to register the fastest growth owing to specialized treatment facilities, skilled surgeons, and growing patient preference for outpatient care.

Regional Analysis

North America generated USD 0.71 billion in 2025 and is expected to reach USD 0.75 billion in 2026, maintaining its leadership position due to high disease prevalence, favorable reimbursement policies, advanced medical technologies, and growing patient awareness.

Europe remained the second-largest regional market, reaching USD 0.60 billion in 2025 and USD 0.63 billion in 2026. Strong healthcare systems, technological adoption, and increasing incidence of kidney stones continue to support regional growth.

Asia Pacific accounted for USD 0.41 billion in 2025 and is projected to reach USD 0.44 billion in 2026. Rapid healthcare infrastructure development, expanding patient populations, rising awareness, and increasing investments by global medical device manufacturers are expected to drive the fastest regional growth during the forecast period.

Latin America generated USD 0.15 billion in 2025, while the Middle East & Africa recorded USD 0.12 billion. Improving healthcare infrastructure and growing awareness regarding minimally invasive treatment options are expected to create new growth opportunities across these emerging markets.

Competitive Landscape

The kidney stone management market is highly competitive, with leading manufacturers focusing on technological innovation, product launches, strategic partnerships, and geographic expansion to strengthen their market presence. Major companies include Boston Scientific Corporation, Olympus Corporation, Cook Medical, STORZ MEDICAL AG, Richard Wolf GmbH, Lumenis, EDAP TMS, DirexGroup, and C.R. Bard (BD). Their continuous investments in advanced laser technologies, flexible ureteroscopes, and minimally invasive surgical solutions are shaping the competitive landscape.

Conclusion

The global kidney stone management market is expected to witness steady growth through 2034, supported by the increasing prevalence of nephrolithiasis, growing preference for minimally invasive surgical procedures, and continuous technological advancements in stone removal devices. With market value projected to increase from USD 1.98 billion in 2025 to USD 3.37 billion by 2034, manufacturers focusing on innovative treatment technologies, improved clinical outcomes, and expansion into emerging healthcare markets are well-positioned to capitalize on future growth opportunities.

Segmentation By Type

• Lithotripsy
• Ureteroscopy
• Percutaneous Nephrolithonomy (PCNL)

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Geography

• North America (the U.S., and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Reimbursement Scenario by Key Countries/Region
• 4.2. Recent Advancements in Kidney Stone Management Devices
• 4.3. Key Industry Trends
• 4.4. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• 4.5. Impact of COVID-19 on Kidney Stone Management Devices Market

5. Global Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Lithotripsy
  • 5.2.2. Ureteroscopy
  • 5.2.3. Percutaneous Nephrolithonomy (PCNL)
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals
  • 5.3.2. Specialty Clinics
  • 5.3.3. Ambulatory Surgical Centers
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Type
  • 6.2.1. Lithotripsy
  • 6.2.2. Ureteroscopy
  • 6.2.3. Percutaneous Nephrolithonomy (PCNL)
• 6.3. Market Analysis - By End User
  • 6.3.1. Hospitals
  • 6.3.2. Specialty Clinics
  • 6.3.3. Ambulatory Surgical Centers
• 6.4. Market Analysis - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Type
  • 7.2.1. Lithotripsy
  • 7.2.2. Ureteroscopy
  • 7.2.3. Percutaneous Nephrolithonomy (PCNL)
• 7.3. Market Analysis - By End User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
  • 7.3.3. Ambulatory Surgical Centers
• 7.4. Market Analysis - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Type
  • 8.2.1. Lithotripsy
  • 8.2.2. Ureteroscopy
  • 8.2.3. Percutaneous Nephrolithonomy (PCNL)
• 8.3. Market Analysis - By End User
  • 8.3.1. Hospitals
  • 8.3.2. Specialty Clinics
  • 8.3.3. Ambulatory Surgical Centers
• 8.4. Market Analysis - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Type
  • 9.2.1. Lithotripsy
  • 9.2.2. Ureteroscopy
  • 9.2.3. Percutaneous Nephrolithonomy (PCNL)
• 9.3. Market Analysis - By End User
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
  • 9.3.3. Ambulatory Surgical Centers
• 9.4. Market Analysis - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Type
  • 10.2.1. Lithotripsy
  • 10.2.2. Ureteroscopy
  • 10.2.3. Percutaneous Nephrolithonomy (PCNL)
• 10.3. Market Analysis - By End User
  • 10.3.1. Hospitals
  • 10.3.2. Specialty Clinics
  • 10.3.3. Ambulatory Surgical Centers
• 10.4. Market Analysis - By Country/Sub-region
  • 10.4.1. GCC Countries
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2021)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles
  • 11.5.1. Cook Medical Inc.
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & Services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. Strategies,
    • 11.5.1.6. Financials (based on availability)
  • 11.5.2. Olympus Corp.
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & Services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. Strategies,
    • 11.5.2.6. Financials (based on availability)
  • 11.5.3. C.R. Bard Inc.
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & Services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. Strategies,
    • 11.5.3.6. Financials (based on availability)
  • 11.5.4. Boston Scientific Corporation
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & Services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. Strategies,
    • 11.5.4.6. Financials (based on availability)
  • 11.5.5. STORZ MEDICAL AG
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & Services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. Strategies,
    • 11.5.5.6. Financials (based on availability)
  • 11.5.6. Richard Wolf GmbH
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & Services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. Strategies,
    • 11.5.6.6. Financials (based on availability)
  • 11.5.7. Lumenis
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & Services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. Strategies,
    • 11.5.7.6. Financials (based on availability)
  • 11.5.8. EDAP TMS
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & Services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. Strategies,
    • 11.5.8.6. Financials (based on availability)
  • 11.5.9. DirexGroup
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products & Services,
    • 11.5.9.3. SWOT analysis,
    • 11.5.9.4. Recent developments,
    • 11.5.9.5. Strategies,
    • 11.5.9.6. Financials (based on availability)
  • 11.5.10. Other prominent players
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products & Services,
    • 11.5.10.3. SWOT analysis,
    • 11.5.10.4. Recent developments,
    • 11.5.10.5. Strategies,
    • 11.5.10.6. Financials (based on availability)

12. Strategic Recommendations